DE3782480D1 - Gefriergetrocknete arzneimittel mit phenylchinolincarbonsaeuren. - Google Patents

Gefriergetrocknete arzneimittel mit phenylchinolincarbonsaeuren.

Info

Publication number
DE3782480D1
DE3782480D1 DE8787112367T DE3782480T DE3782480D1 DE 3782480 D1 DE3782480 D1 DE 3782480D1 DE 8787112367 T DE8787112367 T DE 8787112367T DE 3782480 T DE3782480 T DE 3782480T DE 3782480 D1 DE3782480 D1 DE 3782480D1
Authority
DE
Germany
Prior art keywords
phenylchinoline
medicinal products
carbonic acids
dried medicinal
freezer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787112367T
Other languages
English (en)
Other versions
DE3782480T2 (de
Inventor
Chien-Chin Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Application granted granted Critical
Publication of DE3782480D1 publication Critical patent/DE3782480D1/de
Publication of DE3782480T2 publication Critical patent/DE3782480T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8787112367T 1986-08-28 1987-08-26 Gefriergetrocknete arzneimittel mit phenylchinolincarbonsaeuren. Expired - Fee Related DE3782480T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90125486A 1986-08-28 1986-08-28
US07/060,203 US4889862A (en) 1986-08-28 1987-06-10 Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids

Publications (2)

Publication Number Publication Date
DE3782480D1 true DE3782480D1 (de) 1992-12-10
DE3782480T2 DE3782480T2 (de) 1993-04-08

Family

ID=26739681

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787112367T Expired - Fee Related DE3782480T2 (de) 1986-08-28 1987-08-26 Gefriergetrocknete arzneimittel mit phenylchinolincarbonsaeuren.

Country Status (17)

Country Link
US (1) US4889862A (de)
EP (1) EP0261426B1 (de)
JP (1) JP2629005B2 (de)
KR (1) KR950006218B1 (de)
AU (1) AU602715B2 (de)
CA (1) CA1312824C (de)
DE (1) DE3782480T2 (de)
DK (1) DK168655B1 (de)
ES (1) ES2052530T3 (de)
FI (1) FI90824C (de)
GR (1) GR3006608T3 (de)
HU (1) HU199289B (de)
IE (1) IE60490B1 (de)
IL (1) IL83662A (de)
NO (1) NO873626L (de)
NZ (1) NZ221574A (de)
PT (1) PT85612B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861783A (en) * 1988-04-26 1989-08-29 E. I. Du Pont De Nemours And Company 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
HU206975B (en) * 1991-03-14 1993-03-01 Reanal Finomvegyszergyar Process for producing granulation and veterinary composition comprising water-soluble flumequine complex
US6417167B1 (en) 1997-02-05 2002-07-09 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing shingoglycolipid and process for preparing them
CA2280130C (en) * 1997-02-05 2007-12-18 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing sphingoglycolipid and process for preparing them
TWI232102B (en) * 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
US20060008529A1 (en) * 2004-07-12 2006-01-12 Meyerhoff Mark E Use of additive sites to control nitric oxide release from nitric oxide donors contained within polymers
US20080241208A1 (en) * 2005-06-30 2008-10-02 Charles Shanley Methods, Compositions and Devices For Promoting Anglogenesis
WO2007064895A2 (en) * 2005-12-02 2007-06-07 The Regents Of The University Of Michigan Polymer compositions, coatings and devices, and methods of making and using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US468299A (en) * 1892-02-02 John atkinson
DE433646C (de) * 1923-09-15 1926-09-09 Chem Fab Vorm E Schering Verfahren zur Herstellung in Wasser leicht loeslicher Derivate von Carbonsaeuren derChinolin- und Pyridinreihe
US3681495A (en) * 1969-08-25 1972-08-01 American Home Prod Freeze dried echothiophate iodide compositions
JPS5071816A (de) * 1973-11-02 1975-06-14
US4036954A (en) * 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
AT356278B (de) * 1976-07-12 1980-04-25 Hoffmann La Roche Verfahren zur herstellung von injektions- loesungen
JPS5976017A (ja) * 1983-01-20 1984-04-28 Yamanouchi Pharmaceut Co Ltd 安定なプロスタグランジンｅ類製剤の製法
CA1288436C (en) * 1983-07-22 1991-09-03 David Paul Hesson Phenylquinolinecarboxylic acids and derivatives as antitumor agents
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
DE3329952A1 (de) * 1983-08-19 1985-02-28 Behringwerke Ag, 3550 Marburg Verfahren zur verringerung einer truebung in kontrollseren
EP0179583A1 (de) * 1984-10-04 1986-04-30 Merck & Co. Inc. System zur Verbesserung der Auflösungsgeschwindigkeit in Wasser und der Löslichkeit von schwer löslichen Arzneimitteln

Also Published As

Publication number Publication date
NO873626L (no) 1988-02-29
EP0261426B1 (de) 1992-11-04
HUT45398A (en) 1988-07-28
FI873701A0 (fi) 1987-08-26
ES2052530T3 (es) 1994-07-16
IL83662A0 (en) 1988-01-31
US4889862A (en) 1989-12-26
DK447887A (da) 1988-02-29
KR950006218B1 (ko) 1995-06-12
NZ221574A (en) 1989-11-28
DK447887D0 (da) 1987-08-27
FI90824C (fi) 1994-04-11
GR3006608T3 (de) 1993-06-30
FI873701A (fi) 1988-02-29
NO873626D0 (no) 1987-08-27
HU199289B (en) 1990-02-28
IE872290L (en) 1988-02-28
AU7762287A (en) 1988-03-03
IE60490B1 (en) 1994-07-27
EP0261426A1 (de) 1988-03-30
PT85612A (en) 1987-09-01
FI90824B (fi) 1993-12-31
KR880002507A (ko) 1988-05-09
IL83662A (en) 1991-09-16
JPS63115816A (ja) 1988-05-20
PT85612B (pt) 1990-05-31
DK168655B1 (da) 1994-05-16
CA1312824C (en) 1993-01-19
AU602715B2 (en) 1990-10-25
DE3782480T2 (de) 1993-04-08
JP2629005B2 (ja) 1997-07-09

Similar Documents

Publication Publication Date Title
DE3782840D1 (de) Arzneimittel mit verzoegerter freigabe.
DE3786481D1 (de) Topische antimikrobielle arzneimittel.
DE69003568D1 (de) Arzneimittel mit verzoegerter freigabe.
DE3676248D1 (de) Ubidecarenon enthaltende arzneimittel.
DE68914835D1 (de) Proteinerzeugnisse.
ATA285187A (de) Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel
FI872114A0 (fi) Foerfarande foer tryckning av formade produkter haerledda fraon aramidfibrer.
FI873630A (fi) Stabilt farmaceutiskt preparat.
NO865080L (no) Belegging av naeringsmidler.
PT85882A (de) Arzneimittel enthaltend alpha-halogenierte dicarbonsaeuren
DE3881456D1 (de) Substituierte 2-phenyl-4-chinolincarbonsaeuren.
ATA36088A (de) Regalfoerderzeug
NO890512D0 (no) Artikkelemballasje av hylsetypen.
DE3777124D1 (de) Nahrungsmittelprodukt.
DE3782480D1 (de) Gefriergetrocknete arzneimittel mit phenylchinolincarbonsaeuren.
DE3766436D1 (de) Hydroxyphosphono-carbonsaeuren.
FI905236A0 (fi) Deoxiribonukleosider innehaollande farmaceutiska konsistenser foer laekning av saor.
DE3763519D1 (de) Heilnahrungsmittel.
DE68907392D1 (de) Dysmnesie modifizierende arzneimittel.
DE68909011D1 (de) Flüssiges Eiprodukt.
DE68915160D1 (de) Herstellung von vergorenen nahrungsmittelerzeugnissen.
NO881026D0 (no) Smakspreparater.
DE3880307D1 (de) Perfluoralkene und fluorierungsprodukte davon.
DE3781045D1 (de) Antirheumatisches arzneimittel.
DE68914161D1 (de) Herstellung von prodrogen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DU PONT PHARMACEUTICALS CO., WILMINGTON, DEL., US

8339 Ceased/non-payment of the annual fee